Aphasia
Conditions
Keywords
Aphasia, Speaking therapy, Language therapy, transcranial Direct current stimulation
Brief summary
Aphasia is a frequent symptom after a left hemisphere stroke. It has serious impacts on social, family and professional lives. Aphasic patients need to be rehabilitated. To date, no pharmacological treatment being available only speech and language therapy (SLT) can improve patients, but its efficiency is moderate. Several studies have investigated the link between the recovery of language and neural reorganization. tDCs, a noninvasive technology for modulating neural excitability, could potentiate the effects of the SLT. About 25 studies in literature have described beneficial effects of tDCs coupled with SLT on aphasic patients. However to the investigator knowledge the feasibility of tDCs and speech therapy in clinical pathways has never been investigated. That is why the investigator propose to study in real care conditions how SLT proves more efficient on the recovery of language in a discursive assessment when coupled with active stimulation than with placebo stimulation.
Detailed description
This is a multicenter, cross-over, randomized, controlled and double blind study. 24 patients will be included between November 2015 and November 2017. During each session of speech and language treatment, aphasics will receive a weak 2 milli amperes (electric) current delivered by a tDCs device for 20 minutes. The stimulation will be either active or placebo. Each stage of the cross over will last three weeks. Patients will be administered the usual number of SLT sessions, no particular therapy being imposed. To evaluate the long-time effects of the therapy, three follow-up measures will be proposed.
Interventions
DEVICEtDCs
PROCEDUREimprovement of language for aphasics patients
Aphasics patients receive active stimulation during SLT
DEVICESham tDCS
Aphasics patients control receive sham stimulation during SLT
Sponsors
Fondation Paul Bennetot
Fondation Garches
Centre d'Investigation Clinique et Technologique 805
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient more than 18 years * Aphasic Following a brain injury identified by MRI. * Present a aphasia severity score\> 1 on the Boston Diagnostic Aphasia Examination (BDAE) severity scale. * No Post stroke delay is retained but the patient should be stable from a medical point of view. * Master Of the French language in spoken and written * Affiliated to a social security * Patient Who signed the informed consent
Exclusion criteria
* Other previous neurological pathologies * epileptic crisis during the previous 2 months * Patient denies * Presence of a cranial flap * intracerebral metal hardware Presence * Patient under guardianship * Patient unable to understand the study * Patient subject to an exclusion period for another search.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| change of number of names, without error and not repeated in the speech | Baseline measures: start of Week 1, 2 and 3. Outcomes measures: 1 assessment at the end of the 5 th week, 1 at the beginning of the 7th week, 1 at the end of the 9 th week and 1 at the end of the 10th week. Follow-up measures: 12th, 14th, 16th | The participant must answer a simple question explain me your job or your study. Their production will be recorded and analyzed. For evaluate the stability of participant performances before the stimulation period three based line will be propose. The third base line corresponds to the start of the first stimulation period. After the three week of tdcs coupled with the SLT a new assessment will be realized. One week later begin the new stage of cross over. An assessment will be administered just before and just after the second stimulation period. Then, three follow-up assessments (one all two weeks) will be proposed during one and half month. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| verbal fluency | Baseline measures: start of Week 1, 2 and 3. Outcomes measures: 1 assessment at the end of the 5 th week, 1 at the beginning of the 7th week, 1 at the end of the 9 th week and 1 at the end of the 10th week. Follow-up measures: 12th, 14th, 16th week. | the participant has two minutes to find the most animal names words beginning by letter p. Investigator collect the number of correct words and calculate the standard deviation according to published norms. |
| working memory | baseline measures: start of Week 1, 2 and 3. Outcomes measures: 1 assessment at the end of the 5 th week, 1 at the beginning of the 7th week, 1 at the end of the 9 th week and 1 at the end of the 10th week. Follow-up measures: 12th, 14th, 16th week. | the participant repeats the numbers in the same order or inverted order. Investigator collect the highest group of number repeated |
| visual exploration | baseline measures: start of Week 1, 2 and 3. Outcomes measures: 1 assessment at the end of the 5 th week, 1 at the beginning of the 7th week, 1 at the end of the 9 th week and 1 at the end of the 10th week. Follow-up measures: 12th, 14th, 16th week. | a paper with a lot of drawing is presented to the participant. The participant must delete all the bells as fast as possible. Investigator collect the number of bell omissions |
| every day life scale | Baseline measures: start of Week 1, 2 and 3. Outcomes measures: 1 assessment at the end of the 5 th week, 1 at the beginning of the 7th week, 1 at the end of the 9 th week and 1 at the end of the 10th week. Follow-up measures: 12th, 14th, 16th week. | a questionnaire is proposed to the participant in order to better understanding how is the communication with their close or with unknown person in a conversation or phone |
| likert scale | at the end of the 9 th week, a likert 5 grade scale was proposed. | likert scale are proposed to know how the stimulation is tolerated and accepted by the participant, the patient family and the speech therapist. |
Countries
France
Contacts
Primary ContactPhilippe AZOUVI, MDPHD
Backup ContactNicolas ROCHE, MD
Outcome results
None listed